Medi Assist Healthcare Q4 EBITDA Rs. 483M; FY26 Results Ad Published Under Reg 47
Medi Assist Healthcare Services reported FY26 consolidated revenue of Rs. 9,047.67 million and Q4 EBITDA of Rs. 483 million (margin: 19.94%). The Board recommended a final dividend of Rs. 2 per share and completed the Paramount TPA acquisition for Rs. 4,124.40 million. Newspaper advertisements under Regulation 47 were published on May 10, 2026, confirming the audited results for the quarter and year ended March 31, 2026.

*this image is generated using AI for illustrative purposes only.
Medi Assist Healthcare Services Limited's Board of Directors, at their meeting held on May 09, 2026, approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The statutory audit was conducted by M/s. MSKA & Associates LLP, whose reports carry an unmodified opinion on both standalone and consolidated financial results. The Board meeting commenced at 02:30 p.m. IST and concluded at 05:30 p.m. IST. Subsequently, pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, newspaper advertisements providing an extract of the audited financial results for the quarter and year ended March 31, 2026 were published on May 10, 2026 in 'Business Line' (English Newspaper) and 'Navshakti' (Marathi Newspaper). The trading window for dealing in shares of the Company is closed from April 01, 2026 till May 11, 2026.
Consolidated Financial Performance
Medi Assist Healthcare Services posted consolidated revenue from operations of Rs. 9,047.67 million for the year ended March 31, 2026, compared to Rs. 7,233.21 million in the previous year. Total income for the year stood at Rs. 9,232.44 million against Rs. 7,470.78 million in the prior year. On a quarterly basis, Q4 EBITDA came in at Rs. 483 million versus Rs. 407 million in the same period last year, while the Q4 EBITDA margin stood at 19.94% compared to 21.60% in the year-ago quarter. The following table summarises the key consolidated financial metrics:
| Metric: | Q4 FY26 | Q3 FY26 | Q4 FY25 | FY26 | FY25 |
|---|---|---|---|---|---|
| Revenue from Operations (Rs. mn): | 2,419.86 | 2,396.78 | 1,888.72 | 9,047.67 | 7,233.21 |
| Other Income (Rs. mn): | 12.46 | — | 77.71 | 184.77 | 237.57 |
| Total Income (Rs. mn): | 2,432.32 | — | 1,966.43 | 9,232.44 | 7,470.78 |
| Total Expenses (Rs. mn): | 2,153.28 | — | 1,665.96 | 8,286.97 | 6,352.91 |
| EBITDA (Rs. mn): | 483.00 | — | 407.00 | — | — |
| EBITDA Margin (%): | 19.94 | — | 21.60 | — | — |
| Net Profit before Tax, Exceptional Items (Rs. mn): | 279.04 | 226.63 | 300.47 | 945.47 | 1,117.87 |
| Net Profit before Tax, after Exceptional Items (Rs. mn): | 279.04 | 84.68 | 300.47 | 803.52 | 1,117.87 |
| Net Profit after Tax – Continuing Operations (Rs. mn): | 544.77 | 41.36 | 216.33 | 893.11 | 916.01 |
| Profit for the Period/Year (Rs. mn): | 544.77 | 41.36 | 215.88 | 893.11 | 915.18 |
| Total Comprehensive Income (Rs. mn): | 520.85 | 66.29 | 196.83 | 919.84 | 892.84 |
| Paid-up Equity Share Capital (Rs. mn): | 373.05 | 372.29 | 352.61 | 373.05 | 352.61 |
| Reserves (excl. Revaluation Reserve) (Rs. mn): | — | — | — | 8,015.98 | 5,062.09 |
| Basic EPS (Rs.) – Continuing & Discontinued Ops: | 7.33 | 0.51 | 3.05 | 12.14 | 12.91 |
| Diluted EPS (Rs.) – Continuing & Discontinued Ops: | 7.33 | 0.51 | 3.04 | 12.14 | 12.85 |
Consolidated total assets as at March 31, 2026 stood at Rs. 13,724.62 million compared to Rs. 11,582.27 million as at March 31, 2025. Total equity increased to Rs. 8,524.00 million from Rs. 5,521.57 million. Net cash flows from operating activities for the year were Rs. 1,180.71 million, while net cash used in investing activities was Rs. (1,596.34) million, primarily reflecting the acquisition of Paramount Health Services & Insurance TPA Private Limited.
Standalone Financial Performance
On a standalone basis, Medi Assist Healthcare Services reported revenue from operations of Rs. 2,254.55 million for the year ended March 31, 2026, compared to Rs. 1,505.86 million in the prior year. The following table presents the key standalone financial metrics:
| Metric: | Q4 FY26 | Q3 FY26 | Q4 FY25 | FY26 | FY25 |
|---|---|---|---|---|---|
| Revenue from Operations (Rs. mn): | 635.63 | 574.28 | 425.53 | 2,254.55 | 1,505.86 |
| Profit before Tax (before exceptional items) (Rs. mn): | 193.99 | 157.51 | 147.90 | 688.28 | 445.54 |
| Profit before Tax (after exceptional items) (Rs. mn): | 193.99 | 156.99 | 147.90 | 687.66 | 445.54 |
| Profit after Tax – Continuing Operations (Rs. mn): | 144.97 | 118.33 | 107.31 | 519.86 | 332.08 |
| Profit after Tax – Continuing & Discontinued Ops (Rs. mn): | 144.97 | 118.33 | 107.31 | 519.86 | 332.08 |
| Other Income (Rs. mn): | 51.48 | — | 6.32 | 146.31 | 76.66 |
| Total Income (Rs. mn): | 687.11 | — | 431.85 | 2,400.86 | 1,582.52 |
| Total Expenses (Rs. mn): | 493.12 | — | 283.95 | 1,712.68 | 1,136.98 |
| Total Comprehensive Income (Rs. mn): | 137.74 | — | 101.57 | 515.99 | 325.11 |
| Basic EPS (Rs.): | 1.95 | — | 1.53 | 7.18 | 4.72 |
| Diluted EPS (Rs.): | 1.95 | — | 1.52 | 7.18 | 4.69 |
Standalone total assets as at March 31, 2026 stood at Rs. 5,502.91 million versus Rs. 3,311.16 million as at March 31, 2025. Total equity on a standalone basis rose to Rs. 4,893.88 million from Rs. 2,296.86 million.
Dividend Recommendation
The Board of Directors, at their meeting held on May 09, 2026, recommended a final dividend of Rs. 2 per equity share (face value Rs. 5 per share), representing 40% of face value, for the year ended March 31, 2026. The dividend is payable subject to approval by shareholders at the ensuing Annual General Meeting. The record date, as and when fixed, shall be intimated to the Stock Exchanges. Dividend shall be paid, subject to deduction of tax at source, within 30 days from the date of shareholders' approval at the ensuing AGM.
Key Corporate Developments
During the year, Medi Assist Healthcare Services completed the acquisition of 100% equity stake in Paramount Health Services and Insurance TPA Private Limited on July 01, 2025, upon payment of a purchase consideration of Rs. 4,124.40 million after closing adjustments. Paramount TPA consequently became a wholly-owned subsidiary of Medi Assist Insurance TPA Private Limited (MAITPA) and a step-down subsidiary of the Company. Additionally, on October 10, 2025, the Company allotted 37,01,000 fully paid-up equity shares at Rs. 535 per share via preferential allotment, raising an aggregate consideration of Rs. 1,980.03 million from Massachusetts Institute of Technology (28,90,830 shares; Rs. 1,546.59 million) and 238 Plan Associates LLC (8,10,170 shares; Rs. 433.44 million). As of March 31, 2026, Rs. 496.00 million of the net proceeds remained unspent. During the quarter ended March 31, 2026, the paid-up equity share capital of the Company increased from Rs. 352.61 millions to Rs. 373.05 millions, pursuant to exercise of stock options by certain employees and allotment of 385,863 equity shares and 3,701,000 equity shares by way of preferential allotment.
The consolidated results include exceptional items totalling Rs. 141.95 million for the year ended March 31, 2026, comprising: Rs. 37.68 million towards cyber-security incident costs at Paramount TPA; Rs. 33.27 million towards incremental employee benefit provisions under the New Labour Codes effective November 21, 2025; and Rs. 71.00 million towards a prudential provision made by MAITPA against advances paid to an insurance company customer pending reconciliation. Separately, on April 04, 2025, the Enforcement Directorate conducted a search and seizure operation at certain offices of MAITPA in Ranchi, Jharkhand. Management has assessed that there is no adverse impact on the Group from this matter, and no adjustment has been made in the financial results.
Other Board Decisions
Based on the recommendation of the Audit Committee, the Board approved the appointment of M/s. PricewaterhouseCoopers Services LLP as Internal Auditors of the Company for the financial year 2026-2027. PricewaterhouseCoopers Services LLP is among the leading professional services networks in the world, with more than 364,000 people in 136 countries and 137 territories, providing services across audit and assurance, tax and legal, deals and consulting. Additionally, based on the recommendation of the Nomination & Remuneration Committee, the Board reviewed certain positions operating at the group level and designated the following officials as Senior Managerial Personnel of the Company in accordance with the SEBI Listing Regulations:
| Sr. No.: | Name: | Designation: |
|---|---|---|
| 1. | Ms. Vinaya Natarajan | Chief Legal Officer |
| 2. | Mr. Praveen Samariya | Chief Technology Officer |
| 3. | Mr. Dhruv Rastogi | Chief AI Officer |
Profiles of Newly Designated Senior Managerial Personnel
Ms. Vinaya Natarajan – Chief Legal Officer: Vinaya Natarajan holds a B.A., LLB (Hons) from the National Academy of Legal Studies and Research (NALSAR) and a Masters in Law from the University of London. She has over 17 years of experience in providing strategic, transactional and compliance-related support and advisory in-house to multinational companies. She has previously held senior positions with LTIMindtree, Tata Technologies, Genworks Health and the Hinduja Group.
Mr. Praveen Samariya – Chief Technology Officer: Praveen Samariya has more than 15 years of extensive experience in engineering and technology. He holds bachelor's and master's degrees in Computer Science and Engineering from the Indian Institute of Technology, Delhi. He has previously served as Head of Engineering at Mahindra Logistics, Co-Founder and CTO of AHA Taxis, and CTO and Director at SamayLa.
Mr. Dhruv Rastogi – Chief AI Officer: Dhruv Rastogi has over 16 years of experience across financial services, insurance, and marketing, operating at the intersection of business strategy, product innovation, and AI-led go-to-market execution within regulated enterprise environments. His career includes leading AI and Data Technology teams at Nomura, Edelweiss, Reliance Industries, Vodafone, Idea and IKS Health. He is an IIT Madras alumnus and has led numerous award-winning projects recognised for innovation and impact.
Earnings Call Details
Medi Assist Healthcare Services has scheduled an earnings call to discuss the audited financial results. The key details are as follows:
| Parameter: | Details: |
|---|---|
| Day/Date: | Monday, May 11, 2026 |
| Time: | 08:30 am IST |
| India Dial-In: | +91 22 6280 1131, +91 22 7115 8032 |
| UK (Toll Free): | 08081011573 |
| USA (Toll Free): | 18667462133 |
| Singapore (Toll Free): | 8001012045 |
| Hong Kong (Toll Free): | 800964448 |
| Investor Relations Email: | investor.relations@mediassist.in |
The following senior management members will participate in the earnings call:
| S.No.: | Name: | Designation: |
|---|---|---|
| 1. | Dr. Vikram Chhatwal | Chairman and Whole-time Director |
| 2. | Mr. Satish Gidugu | Chief Executive Officer and Whole-time Director |
| 3. | Mr. Sandeep Daga | Chief Financial Officer |
Participants are encouraged to pre-register for the call to connect without waiting for operator assistance. Upon registration, participants will receive dial-in numbers, a passcode, and a pin on their registered email address. The intimation has been signed by Rashmi B V, Company Secretary & Compliance Officer (ICSI Membership No: A38729), and is available on the Company's website at www.mediassist.in .
Historical Stock Returns for Medi Assist Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.69% | -5.43% | +7.16% | -26.21% | -27.53% | -20.84% |
How will the full-year integration of Paramount TPA impact Medi Assist's consolidated EBITDA margins in FY27, given the cybersecurity incident costs and pending reconciliation provisions that weighed on FY26 results?
What strategic role will Chief AI Officer Dhruv Rastogi play in leveraging AI to improve claims processing efficiency and loss ratios, and could this create a competitive moat in the TPA industry?
With Rs. 496 million of preferential allotment proceeds still unspent as of March 31, 2026, what acquisition or expansion targets is Medi Assist likely to pursue to further consolidate the fragmented TPA market?


































